Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

7,426 total articles

BofA Highlights Four Biotech Names Positioned for Potential 2026 Upside

BofA Highlights Four Biotech Names Positioned for Potential 2026 Upside

Bank of America analysts have identified four biotechnology companies they view as top investment ideas for 2026, each supported by specific commercial drivers or upcoming clinical milestones. Their selections - Argenx, KalVista Pharmaceuticals, Ocular Therapeutix and Vertex Pharmaceuticals - carry Buy ratings and price objectives that reflect proj…

Aumovio to Cut Up to 4,000 R&D Roles as It Reins in Costs

Aumovio to Cut Up to 4,000 R&D Roles as It Reins in Costs

Aumovio SE announced plans to eliminate as many as 4,000 research and development positions worldwide as part of a cost-control plan in a challenging market environment. The company said the reductions will be mostly complete by the end of 2026 and will include a voluntary redundancy program in Germany beginning in March. The move accompanies a tar…

Omeros Begins Commercial Shipments of YARTEMLEA; Shares Tick Higher

Omeros Begins Commercial Shipments of YARTEMLEA; Shares Tick Higher

Omeros Corporation's stock edged up after the company said it has completed first commercial shipments of YARTEMLEA (narsoplimab-wuug) to distributors and that transplant centers are beginning to place orders. The therapy, approved by the FDA for adults and children aged two and above, is now being administered to both adult and pediatric patients …

Kepler Cheuvreux Names Five European Capital Goods Picks for 2026

Kepler Cheuvreux Names Five European Capital Goods Picks for 2026

Kepler Cheuvreux has published a sector review of European capital goods, screening 75 companies with market capitalizations above EUR2 billion to identify preferred and least preferred names for 2026. The research highlights concentrated growth in the US and India, strength in data centers and infrastructure-related markets, and mixed prospects ac…

Stocks Swing Widely as Healthcare Names Lead Declines and Tech, Semiconductors Post Gains

Stocks Swing Widely as Healthcare Names Lead Declines and Tech, Semiconductors Post Gains

Trading on Tuesday produced sharp moves across market-cap bands, with large healthcare insurers among the weakest names after policy news and a mix of gains in semiconductors, cloud and data center-related stocks. Mega-cap losses included UnitedHealth, while Humana and CVS were large-cap decliners. A range of mid- and small-cap companies also recor…

Cantor Launches Fintech Coverage, Says Financial 'Plumbing' Is Being Rebuilt

Cantor Launches Fintech Coverage, Says Financial 'Plumbing' Is Being Rebuilt

Cantor Fitzgerald initiated coverage of fintech and payments stocks, arguing that blockchain and artificial intelligence are driving a fundamental redesign of how money and assets move across accounts, balance sheets, and jurisdictions. The firm warns the change is obscured to many end users by modern interfaces built atop legacy systems, and ident…